Xcell Biosciences Overview
- Year Founded
-
2012

- Status
-
Private
- Employees
-
29

- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.4M
- Investors
-
20
Xcell Biosciences General Information
Description
Developer of a bench-top primary cell control system designed to advance immunotherapy research and manufacturing, empowering scientists with better tools for cell maintenance, expansion, and control. The company's technology supports a range of primary cell types, including immune, stem, and tumor cells, enabling clients with predictive therapy development and improved clinical outcomes.
Contact Information
Website
www.xcellbio.comCorporate Office
- 455 Mission Bay Boulevard South
- San Francisco, CA 94158
- United States
Corporate Office
- 455 Mission Bay Boulevard South
- San Francisco, CA 94158
- United States
Xcell Biosciences Timeline
Xcell Biosciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Later Stage VC | 17-Dec-2024 | $1.4M | Completed | Generating Revenue | ||
6. Later Stage VC (Series B) | 14-Jun-2024 | Completed | Generating Revenue | |||
5. Later Stage VC (Series B) | 13-Sep-2021 | Completed | Generating Revenue | |||
4. Later Stage VC (Series A) | 23-Feb-2017 | Completed | Generating Revenue | |||
3. Seed Round | 01-May-2015 | Completed | Startup | |||
2. Accelerator/Incubator | Completed | Startup | ||||
1. Accelerator/Incubator | Completed | Startup |
Xcell Biosciences Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | ||||||||
Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Xcell Biosciences Comparisons
Industry
Financing
Details
Xcell Biosciences Competitors (8)
One of Xcell Biosciences’s 8 competitors is Sphere Fluidics, a Venture Capital-Backed company based in Cambridge, United Kingdom.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Sphere Fluidics | Venture Capital-Backed | Cambridge, United Kingdom | ||||
Oxford Nanopore Technologies | Formerly VC-backed | Oxford, United Kingdom | ||||
Cytena | Formerly VC-backed | Freiburg, Germany | ||||
HiFiBiO Therapeutics | Venture Capital-Backed | Cambridge, MA | ||||
Pacific Biosciences | Formerly VC-backed | Menlo Park, CA |
Xcell Biosciences Patents
Xcell Biosciences Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240002774-A1 | Multiple incubator cell culture system with atmospheric regulation operated by an integrated control system | Pending | 04-Aug-2020 | ||
GB-202213128-D0 | Gas and liquid flow regulation system for cell culture | Pending | 14-Feb-2020 | ||
GB-2608310-A | Gas and liquid flow regulation system for cell culture | Pending | 14-Feb-2020 | ||
US-20230212500-A1 | Gas and liquid flow regulation system for cell culture | Pending | 14-Feb-2020 | ||
EP-4103201-A1 | Gas and liquid flow regulation system for cell culture | Pending | 14-Feb-2020 | C12M41/40 |
Xcell Biosciences Signals
Xcell Biosciences Investors (20)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Avego Management | PE/Buyout | Minority | ||
Berkeley SkyDeck | Accelerator/Incubator | Minority | ||
Casdin Capital | Venture Capital | Minority | ||
Dynamk Capital | Venture Capital | Minority | ||
Formic Ventures | Venture Capital | Minority |
Xcell Biosciences FAQs
-
When was Xcell Biosciences founded?
Xcell Biosciences was founded in 2012.
-
Where is Xcell Biosciences headquartered?
Xcell Biosciences is headquartered in San Francisco, CA.
-
What is the size of Xcell Biosciences?
Xcell Biosciences has 29 total employees.
-
What industry is Xcell Biosciences in?
Xcell Biosciences’s primary industry is Discovery Tools (Healthcare).
-
Is Xcell Biosciences a private or public company?
Xcell Biosciences is a Private company.
-
What is Xcell Biosciences’s current revenue?
The current revenue for Xcell Biosciences is
. -
How much funding has Xcell Biosciences raised over time?
Xcell Biosciences has raised $61.8M.
-
Who are Xcell Biosciences’s investors?
Avego Management, Berkeley SkyDeck, Casdin Capital, Dynamk Capital, and Formic Ventures are 5 of 20 investors who have invested in Xcell Biosciences.
-
Who are Xcell Biosciences’s competitors?
Sphere Fluidics, Oxford Nanopore Technologies, Cytena, HiFiBiO Therapeutics, and Pacific Biosciences are some of the 8 competitors of Xcell Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »